Sophiris Bio Inc. (NASDAQ:SPHS): Sabby Capital Reports Large New Stake
Hal Mintz's Sabby Capital recently filed a Form 13G with the SEC, in which it reported the acquisition of 2.48 million common shares of Sophiris Bio Inc.
Posts Tagged ‘Hal Mintz’
13G Filing: Sabby Capital Opens Large Position in Rexahn Pharmaceuticals, Inc. (RNN)
Hal Mintz's Sabby Capital has revealed a new position in Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) through a 13G filing with the SEC.
Buffett Buys More Shares of This Energy Company, Carlson Reaches Agreement With Vitamin Shoppe Inc. (VSI), Plus Two Other Moves
The HFRX Absolute Return Index, which measures the overall returns of the hedge fund industry, posted a negative return of 0.09% in 2015, which compares with a negative return...
After Monster Q1, Hal Mintz’s Stock Picks Have Another Strong Quarter
Sabby Management is a New Jersey-based activist hedge fund launched by Hal Mintz in June 2011.
Healthcare Investing Maven Hal Mintz Just Opened A Big Position In This Biotech Firm
According to a 13G form filed with the Securities and Exchange Commission, Hal Mintz’s Sabby Management has acquired a new passive stake in OncoSec Medical Incorporated (NASDAQ...
ACADIA Pharmaceuticals Inc. (ACAD), Pfizer Inc. (PFE): Sabby Management Rewarded for Its Healthcare Picks
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) spiked nearly 18% during Tuesday's intraday trading and hit a 52-week high of $46.48.
3 Stocks Hedge Funds Just Bought; Should You?
We have a trifecta of recent hedge fund buying activity for you to digest, featuring three different funds and three different stocks.
Digimarc Corp (DMRC), Eleven Biotherapeutics Inc (EBIO): Rima Senvest Management and Sabby Management Are Bullish on These Micro-Caps
Digimarc Corp (NASDAQ:DMRC) and Eleven Biotherapeutics Inc (NASDAQ:EBIO) are two companies on which two funds have been bullish recently.
Aegerion Pharmaceuticals Inc. (AEGR), Cytori Therapeutics Inc (CYTX): Scopia Capital and Sabby Capital Are Bullish on These Stocks
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) continues to feel hedge funds’ bullishness.
Lpath, Inc. (LPTN), Oplink Communications, Inc (OPLK): Sabby Management and Engaged Capital’s Latest SEC Filings
Hal Mintz's Sabby Management and Glenn W. Welling's Engaged Capital reported changes to their stakes in Lpath, Inc.
Aastrom Biosciences Inc (ASTM), The Providence Service Corporation (PRSC): Sabby Capital’s & Coliseum Capital’s Latest Moves
In two different filings with the U.S.
Hal Mintz And Sabby Capital Disclose New Investments In StemCells Inc (STEM) And Skystar Bio-Pharmaceutical Company (SKBI)
Hal Mintz, the manager of Sabby Capital, believes StemCells Inc (NASDAQ:STEM) is a good investment and has opened a position for his fund.
Sabby Capital Reveals New 7.3% Stake In RiceBran Technologies (RIBT)
RiceBran Technologies (NASDAQ:RIBT) has caught the attention of Hal Mintz, who has initiated a new position.
Healthcor Management Initiates Exposure to Oxygen Biotherapeutics, Inc. (OXBT)
Arthur Cohen and Joseph Healey's Healthcor Management has added Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) to its equity portfolio.
Adage Capital Management Discloses New Stake in OvaScience Inc (OVAS)
A new filing with the SEC shows that Phill Gross and Robert Atchinson's Adage Capital Management has initiated a stake in OvaScience Inc (NASDAQ:OVAS).
Hal Mintz, Sabby Management Report 7.43% Stake in Oxygen Biotherapeutics, Inc. (OXBT)
Hal Mintz' Sabby Management has reported a new stake in the biotechnology company Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT), a new filing with the SEC shows.
Sabby Management Adds Bioline RX Ltd (BLRX) & Recro Pharma Inc (REPH) to Its Equity Portfolio
In a couple of new filings with the SEC, Hal Mintz's Sabby Management disclosed adding two companies to its equity portfolio: Bioline RX Ltd (NASDAQ:BLRX) and Recro Pharma Inc...
Deerfield Management Boosts Its Stake in OvaScience Inc (OVAS)
Deerfield Management, led by James E.
Kevin Kotler’s Broadfin Capital Reports New Stake In MELA Sciences Inc (MELA)
Kevin Kotler’s Broadfin Capital, in its latest filing with the Securities and Exchange Commission, has reported ownership of 9.09 million shares of MELA Sciences Inc (NASDAQ...
Make That 2 Biotech Stocks Today: Sabby Management Reveals It Bought Advaxis
Sabby Management, Advaxis: Advaxis, Inc. (NASDAQ:ADXS), a micro-cap biotech development company, has just seen Hal Mintz's Sabby Management disclose a 6.3% stake.
Sabby Management Joins Alpha Capital Anstalt in DARA Biosciences With 8.3% Stake
Sabby Management, Dara Biosciences: In a new 13G filing just reported to the SEC, Hal Mintz's Sabby Management reported an 8.3% stake in DARA Biosciences Inc (NASDAQ:DARA) stock...
